2637.HK
HAIXI PHARMA
HK$143.00
+2.58%
2026-02-27
About HAIXI PHARMA
Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China.
Key Fundamentals
P/E Ratio
75.86
Forward P/E
69.92
EPS (TTM)
HK$2.95
ROE
16.6%
Profit Margin
30.4%
Price/Book
9.56
Market Cap
HK$17.61B
Avg Volume (10D)
135K
Recent Breakout Signals
No recent breakout signals detected for 2637.HK.
Recent Price Range (60 Days)
60D High
HK$161.70
60D Low
HK$124.00
Avg Volume
68K
Latest Close
HK$143.00
Get breakout alerts for 2637.HK
Sign up for Breakout Scanner to receive daily notifications when 2637.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
HAIXI PHARMA (2637.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2637.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2637.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.